Sensate is a technology company.
Sensate has raised $3.0M across 1 funding round.
Sensate has raised $3.0M in total across 1 funding round.
Sensate has raised $3.0M in total across 1 funding round.
Sensate's investors include Bloomberg Beta, Geek Ventures, Share Ventures.
Sensate is a wellness technology company that develops a wearable device for stress relief and relaxation, targeting the vagus nerve through infrasonic waves and bone conduction vibrations paired with a mobile app's soundscapes.[1][2][3][4] It serves individuals seeking non-invasive mental health support, solving problems like acute stress, anxiety, poor sleep, and low resilience by activating the parasympathetic nervous system in as little as 10 minutes without requiring meditation training.[1][2][4] The company, founded in 2016 and headquartered in Taunton, England, has raised $5.1M in seed VC funding, achieved 387% YoY revenue growth to $2.8M in 2021, and maintains strong customer ratings amid a booming mental health wearables market.[1][3]
Sensate was founded in 2016 by CEO Anna Gudmundson, a leader in integrated medicine, alongside co-founders who aimed to democratize vagus nerve stimulation for everyday stress management.[1][2][3] The idea emerged from Gudmundson's expertise in making profound relaxation accessible without years of training, leading to a patented device using sonic resonance on the sternum to calm the nervous system—opposite the fight-or-flight response.[3][4] Early traction built through venture backing from firms like Unlock Venture Partners and TenOneTen, culminating in a revenue surge from $583K in 2020 to $2.8M in 2021, plus crowdfunding on Wefunder at an $18M valuation.[1][3]
Sensate stands out in the mental health wearables space (ranked as a Challenger alongside Muse and Apollo) through these key advantages:
Sensate rides the explosive growth of mental health wearables, a market addressing rising demand for proactive tools tracking stress via sensors for heart rate variability, sleep, and anxiety amid global mental health crises.[1] Timing aligns with post-pandemic wellness booms, where consumers favor hardware-software combos over apps alone, fueled by remote work stress and aging populations seeking natural nervous system hacks.[1][3] Favorable forces include VC interest in biotech-wellness crossovers and regulatory tailwinds for non-pharma solutions; Sensate influences the ecosystem by pioneering consumer vagus nerve tech, challenging incumbents, and validating bone conduction for broader adoption in relaxation devices.[1][3][4]
Sensate is poised to scale beyond its $2.8M 2021 revenue through expanded distribution, app enhancements, and potential Series A funding, targeting mainstream wellness parity with firms like Headspace.[3] Trends like AI-personalized soundscapes, B2B enterprise wellness integrations, and hybrid vagus tech (e.g., with wearables like Apple Watch) will propel growth, especially as mental health spending surges.[1][3] Its influence could evolve from niche challenger to category leader, empowering accessible resilience in a high-stress world—echoing its founding mission to deliver meditation's benefits without the grind.[2][3][4]
Sensate has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2023 | $3.0M Seed | Bloomberg Beta, Geek Ventures, Share Ventures |